A detailed history of Perfromance Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 6,436 shares of AMGN stock, worth $1.69 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,436
Previous 2,135 201.45%
Holding current value
$1.69 Million
Previous $667,000 210.79%
% of portfolio
0.07%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$309.38 - $337.38 $1.33 Million - $1.45 Million
4,301 Added 201.45%
6,436 $2.07 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $7.25 Million - $8.81 Million
-27,604 Reduced 92.82%
2,135 $667,000
Q1 2024

Apr 30, 2024

SELL
$268.87 - $324.56 $41,405 - $49,982
-154 Reduced 0.52%
29,739 $8.46 Million
Q4 2023

Jan 22, 2024

SELL
$255.7 - $288.46 $102,024 - $115,095
-399 Reduced 1.32%
29,893 $8.61 Million
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $233,518 - $289,919
1,068 Added 3.65%
30,292 $8.14 Million
Q2 2023

Jul 13, 2023

BUY
$214.27 - $253.37 $54,210 - $64,102
253 Added 0.87%
29,224 $6.49 Million
Q1 2023

Apr 20, 2023

BUY
$225.79 - $275.2 $437,806 - $533,612
1,939 Added 7.17%
28,971 $7 Million
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $13,054 - $16,587
57 Added 0.21%
27,032 $0
Q3 2022

Oct 17, 2022

SELL
$224.46 - $253.15 $113,127 - $127,587
-504 Reduced 1.83%
26,975 $6.08 Million
Q2 2022

Jul 15, 2022

SELL
$230.71 - $256.74 $228,402 - $254,172
-990 Reduced 3.48%
27,479 $6.69 Million
Q1 2022

Apr 21, 2022

SELL
$219.27 - $242.57 $617,025 - $682,591
-2,814 Reduced 9.0%
28,469 $6.88 Million
Q4 2021

Feb 03, 2022

BUY
$198.88 - $227.6 $6.22 Million - $7.12 Million
31,283 New
31,283 $7.04 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Perfromance Wealth Partners, LLC Portfolio

Follow Perfromance Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.